Skip to main content

Table 4 Number and frequency of every HLA-B allele found in our population for each group

From: HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina

B

Population

Overall

Allele frequency

NII

AC

ATLL

HAM

HLA-B*07

1

2

0

0

3

0.027

HLA-B*08

2

2

0

3

7

0.063

HLA-B*13

0

0

0

1

1

0.009

HLA-B*14

2

2

1

2

7

0.063

HLA-B*15

0

0

0

2

2

0.018

HLA-B*18

0

0

2

0

2

0.018

HLA-B*27

2

0

0

0

2

0.018

HLA-B*35

8

2

3

15

28

0.25

HLA-B*38

4

4

0

0

8

0.071

HLA-B*39

5

4

4

2

15

0.134

HLA-B*40

2

0

0

0

2

0.018

HLA-B*41

0

0

0

1

1

0.009

HLA-B*44

0

2

1

1

4

0.036

HLA-B*48

0

8

0

0

8

0.071

HLA-B*49

0

0

0

1

1

0.009

HLA-B*51

0

3

2

5

10

0.089

HLA-B*52

0

2

0

2

4

0.036

HLA-B*53

0

6

0

0

6

0.054

HLA-B*55

0

0

0

1

1

0.009

Overall

26

37

13

36

112

1

  1. NII non infected individual, AC Asymptomatic Carrier, ATLL Adult T cell leukemia/lymphoma, HAM HTLV-1- associated myelopathy